The novel cyclophilin inhibitor C105SR reduces hepatic ischaemia–reperfusion injury via mitoprotection

Archive ouverte

Kheyar, Amel | Ahnou, Nazim | Ahmed-Belkacem, Abdelhakim | Hulin, Anne | Pressiat, Claire | Ghaleh, Bijan | Guichou, Jean-François | Morin, Didier | Pawlotsky, Jean-Michel | Teixeira-Clerc, Fatima

Edité par CCSD ; Elsevier -

International audience.

Study of the ability to inhibit CypD peptidyl-prolyl cis-trans isomerase (PPIase) activity and of mitoprotective properties

CypD PPIase activity assay

Mitochondrial swelling assay
Mitochondrial calcium retention capacity assay
Isolated mouse liver mitochondria 1 compound
Study of the ability to inhibit mitochondrial permeability transition pore opening and cell death
In vitro hypoxia/reoxygenation model
Mouse hepatocyte cell line
Study of the hepatoprotective properties
Identification of credible lead compound for subsequent clinical development

In vivo hepatic ischemia/reperfusion injury model

compounds
Cyclophilin inhibitor synthesis

Chemical optimization R1

Suggestions

Du même auteur

Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury

Archive ouverte | Panel, Mathieu | CCSD

International audience. Background & Aims: Hepatic ischemia-reperfusion injury is a complication of liver surgery that involves mitochondrial dysfunction resulting from mitochondrial permeability transition pore (mP...

A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution

Archive ouverte | Panel, Mathieu | CCSD

International audience

Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti- Flaviviridae Activity

Archive ouverte | Nevers, Quentin | CCSD

International audience. Although members of the Flaviviridae display high incidence, morbidity, and mortality rates, the development of specific antiviral drugs for each virus is unlikely. Cyclophilins, a family of ...

Chargement des enrichissements...